Psychometric validation of the Bengali version of the 10 item MARS(Medication Adherence Rating Scale) among bipolar disorder patients, Kolkata West Bengal.
DOI:
https://doi.org/10.37506/y7fh4346Keywords:
Medication adherence rating scale, bipolar disorder, adherence, compliance.Abstract
Background: Bipolar affective is a chronic mental illness, where recurrence is very common .Bipolar patients have low or partial adherence rate to treatment. The MARS is a 10 item self report measure of medication compliance. Medication adherence is a vital predictor of illness course and outcome in patients with bipolar disorder.
Aim: 1. To validate the English to Bengali translation of MARS.
- To establish the reliability of the MARS scale.
Material and Method: The original scale was translated to Bengali version by the following process:
- Establishment of a bilingual group of experts.2. Examination of the conceptual structure of the instrument under study by the experts. 3. Translation 4. Examination of the translation by the experts. 5. Examination of the translation by a monolingual group. 6. Blind back translation7. Examination of the blind back translation by the experts.
The Psychometric properties of MARS-B were validated among the bipolar patients (N=100).
Data were collected during the period of May 2023 to July2023.by interviewing with simple random sampling and analyzed by statistical package of social science(SPSS -16) and MS Excel 2010 version software.
Results:
This study report shows good reliability Cronbach’s (α) 0.71 of MARS (Bengali) version. principal-components analysis extracted four factors from the MARS that together accounted for 55% of the variance. These factors were then subjected to a Varimax rotation revealing the factors of ‘Medication adherence behavior’, ‘Health status and wellbeing causes medication adherence’, ‘Perception regarding benefits of medication adherence’,and ‘Negative side effects towards psychotropic medication’ .
Conclusion: This study shows that MARS Bengali version is valid, reliable and applicable in clinical practice, research, public health and primary health care in west Bengal.
References
Leclerc E, Mansur RB, Brietzke E. Determinants of adherence to treatment in bipolar disorder: A comprehensive review. J Affect Disord. 2013;149(1-3):247-52.
Vieta E, Rosa AR, Martinez-Aran A, et al. Psychiatrist perceptions of potential reasons for non and partial adherence to medication: Results of a survey in bipolar disorder from eight European countries. J Affect Disord. 2012;140(1):125-30.
Gianfrancesco FD, Rajagopalan K, Sajatovic M, Wang RH. Antipsychotic treatment adherence and associated mental health care use among individuals with bipolar disorder. Clin Ther. 2008;30(7):1358-74.
Lobban F, Barrowclough C, Jones S. A review of the role of illness models in severe mental illness. Clin Psychol Rev. 2003;23(2):171-96.
Levin JB, Aebi ME, Howland M, Barboza M, Eskew L, Tatsuoka C, et al. The relationship between medication attitudes and medication adherence behavior in adults with bipolar disorder. J Nerv Ment Dis. 2020;208(2):87-93.
Consoloni JL, M'Bailara K, Perchec C, Aouizerate B, Aubin V, Azorin JM, et al. Trajectories of medication adherence in patients with bipolar disorder along 2 years follow-up. J Affect Disord. 2021;282:812-9.
Berk L, Hallam KT, Colom F, Vieta E, Hasty M, Macneil C, Berk M. Enhancing medication adherence in patients with bipolar disorder. Hum Psychopharmacol. 2010;25(1):1-16.
Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, Docherty JP; Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70 Suppl 4:1-46; quiz 47-8.
IBM. SPSS Statistics 22.0 (2020). Available from: http://www.ibm.com/support/pages/spss-statistics-220-available-download.
Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 2000;42(3):241-7.
Richardson M, McCabe R, Priebe S. Are attitudes towards medication adherence associated with medication adherence behaviours among patients with psychosis? A systematic review and meta-analysis. Soc Psychiatry Psychiatr Epidemiol. 2013;48(4):649-57.
Fialko L, Garety PA, Kuipers E, Dunn G, Bebbington PE, Fowler D, et al. A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophr Res. 2008;100(1-3):53-9.
Owie GO, Olotu SO, James BO. Reliability and validity of the Medication Adherence Rating Scale in a cohort of patients with schizophrenia from Nigeria. Trends Psychiatry Psychother. 2018;40(2):85-92. Available from: https://doi.org/10.1590/2237-6089-2017-0077.
Fond G, Boyer L, Boucekine M, Aden LA, Schürhoff F, Tessier A, et al. Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset. Schizophr Res. 2017;182:84-9.
Zemmour K, Tinland A, Boucekine M, Girard V, Loubière S, Resseguier N, et al. Validation of the Medication Adherence Rating Scale in homeless patients with schizophrenia: Results from the French Housing First experience. Sci Rep. 2016;6:31598.
Flaherty JA, Gaviria FM, Pathak D, et al. Developing instruments for cross-cultural psychiatric research. J Nerv Ment Dis. 1988;176:257-63.
RobertF. De Vellis, Scale Development: Theory and Applications Fourth Edition, Los Angels: SAGE[2017] University of North Carolina ,Chapel Hill, USA:200-204
Lam WY, Fresco P. Medication adherence measures: An overview. Biomed Res Int. 2015;2015:217047.
Hogan TP, Awad AG, Eastwood MR. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med. 1983;13(1):177-83.
. American Psychiatric Association(2013.Diagnostic and statistical manual of mental Disorders(5th Ed. Washington DC,97.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Mita Basak Mandal, Aparna Ray, Gautam Bandyopadhyay, Saikat Bhattacharya
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.